Clinical Trial Update: A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the efficacy and safety of aprocitentan in resistant hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• Aprocitentan (aprocitentan)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Resistant Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2023-03-21